Product Images Buspirone Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 16 images provide visual information about the product associated with Buspirone Hydrochloride NDC 75834-267 by Nivagen Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - buspirone 01

Chemical Structure - buspirone 01

Image - buspirone 02

Image - buspirone 02

Image - buspirone 03

Image - buspirone 03

Image - buspirone 04

Image - buspirone 04

Image - buspirone 05

Image - buspirone 05

Image - buspirone 06

Image - buspirone 06

Image - buspirone 07

Image - buspirone 07

Image - buspirone 08

Image - buspirone 08

Image - buspirone 09

Image - buspirone 09

Image - buspirone 10

Image - buspirone 10

Image - buspirone 11

Image - buspirone 11

PRINCIPAL DISPLAY PANEL - 5 mg Tablet Bottle Label - buspirone 12

PRINCIPAL DISPLAY PANEL - 5 mg Tablet Bottle Label - buspirone 12

This is a medication called Ach Abet with NDC number 75834-266-01 manufactured by InventiaHealthcars. It contains buspirone hydrochloride, USP and is stored in tablets USP. The package insert contains information on the recommended dosage, and the medication should be dispensed in a tight, light-resistant container, with a child-resistant closure. The manufacturing date is indicated as well as the expiration date. This medication is intended for human consumption.*

PRINCIPAL DISPLAY PANEL - 7.5 mg Tablet Bottle Label - buspirone 13

PRINCIPAL DISPLAY PANEL - 7.5 mg Tablet Bottle Label - buspirone 13

This is a description of a medication with the National Drug Code (NDC) 75834-267-01. The medication is in the form of tablets containing 7.5 mg of busPIRone Hydrochloride, USP. The package contains 100 tablets and should be stored in a place with a controlled USP room temperature of 20° to 25°C (68° to 77°F). The medication is manufactured by Inventia Healthcare Limited in India and distributed in the United States by Nivagen Pharmaceuticals, Inc. The prescription for the medication can be found in the package insert. The medication should be kept out of reach of children and dispensed in a light-resistant container with a child-resistant closure. The lot number is "RRERIRIRIK," and the manufacturing date is "3. K%." The expiration date is "14R.RRRR."*

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label - buspirone 14

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label - buspirone 14

Each tablet of this medication contains 10mg of buspirone hydrochloride, USP, manufactured by Inventia Healthcare Limited in India. The package insert contains usual dosage information and the medication is manufactured for Pramaceuticals in Sacramento, CA. This medication should be stored at controlled room temperature and kept out of the reach of children. The lot number is ATEO745L/01 and the expiration date is 10/12/2020.*

PRINCIPAL DISPLAY PANEL - 15 mg Tablet Bottle Label - buspirone 15

PRINCIPAL DISPLAY PANEL - 15 mg Tablet Bottle Label - buspirone 15

This is a medication package of BusPIRone Hydrochloride Tablets, USP manufactured by Inventia Healthcare Limited in India and distributed by Nivagen Pharmaceuticals, Inc. in Sacramento, CA, USA. The tablets are intended for human consumption and one package contains 100 tablets, each containing 15 mg of the active ingredient buspirone hydrochloride. The package insert contains the prescribing information, and it is recommended to store the tablets in a tight, light-resistant container. The medication should be kept out of the reach of children. The manufacturing license number is KD/638, and the revision date of the package is 10/2020.*

PRINCIPAL DISPLAY PANEL - 30 mg Tablet Bottle Label - buspirone 16

PRINCIPAL DISPLAY PANEL - 30 mg Tablet Bottle Label - buspirone 16

This is a description of a medication with the NDC number 75834-270-60. The medication is busPIRone Hydrochloride, in tablet form containing 30 mg of the active ingredient, and is manufactured by Inventia Healthcare Limited in India. The tablets come in a pack of 60, and there is a toll-free number for more information. The package includes a patient information leaflet, and the pharmacist is instructed to store the medication at 20-25°C in a tightly sealed, light-resistant container that is child-resistant. The dosage information can be found in the package insert, and the medication should be kept out of the reach of children. No information is available about the medication's uses or side effects.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.